Paul Gardner

Paul Gardner practices at NYU Langone - Tisch Hospital in New York, New York.

Paul Gardner's NPI, 1407936271, was assigned on October 16, 2006. Paul Gardner graduated from University of Pittsburgh School of Medicine in 2001. Paul Gardner holds Pennsylvania license MD422825.

Paul Gardner's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Paul Gardner's primary practice is NYU Langone - Tisch Hospital in New York, New York. Paul Gardner is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Paul Gardner to 5 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Paul Gardner practices, 6 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Paul Gardner's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Paul Gardner is board certified in neurological surgery by the American Board of Neurological Surgery. Paul Gardner is licensed in Pennsylvania.

Dmand AI lists back and neck pain treatment without fusion, craniotomy, spinal fusion and thoracic spine disorders among the conditions Paul Gardner treats.

CMS data shows 162 Medicare services from Paul Gardner across 6 procedure codes in 2024, for 124 Medicare patients. Medicare paid $42,161 for them.

CMS counts 124 Medicare patients who saw Paul Gardner in 2024. The largest group is 65 to 74, with 65 patients. 72% of them have high blood pressure, and 72% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Paul Gardner's median patient age at 65, with 60% women.

In 2024, Paul Gardner wrote 63 Medicare Part D claims for 34 patients. 97% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $798 in total drug cost. In 2023, CMS named 74 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Paul Gardner for performance year 2024, reported as part of a group. Paul Gardner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Paul Gardner as offering telehealth.

Dmand AI links 457 papers to Paul Gardner, published from 2005 to 2025. 2023 was the busiest year, with 34. The most frequent topics are Endoscopy, Skull Base and Skull Base Neoplasms. Paul Gardner has published most often in J Neurosurg. Paul Gardner's most frequent co-authors are Eric Wesley Wang, MD, Ricardo L. Carrau, MD and Garret Wayne Choby, MD.

Dmand AI links Paul Gardner to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Cerebral Hemorrhage, Meningioma and Intracranial Hemorrhages.

CMS Open Payments shows 86 general payments to Paul Gardner from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Stryker Corporation paid the most, $15,791.

Dmand AI lists 1 award for Paul Gardner.

Paul Gardner graduated from University of Pittsburgh School of Medicine in 2001. Paul Gardner is a member of AANS and CNS.

Paul Gardner is in network with 7 carriers, including Aetna, Excellus BlueCross BlueShield and Cigna. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.